A Study to Efficacy and Safety of CWP-0403 in Type 2 Diabetes Mellitus Patients

NCT01529528 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Anagliptin
DRUG: Anagliptin
DRUG: Placebo of Anagliptin

Sponsor

JW Pharmaceutical